ArticleNeuro-oncology2018

A study of the focal adhesion kinase inhibitor GSK2256098 in patients with recurrent glioblastoma with evaluation of tumor penetration of [11C]GSK2256098.

Nicholas F Brown et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.